Propanc BiopharmaPPCB
13F holders, Q4 2025 (December 31)5holders +2
3new positions
1sold out
$0.54avg. 13F price*
At the end of Q4 2025, 5 institutions reported holding Propanc Biopharma Inc. (PPCB) in their 13F filings, up 2 from Q3 2025. 3 opened new positions and 1 sold out. The largest holders were Marex Group Ltd ($35K), Two Sigma Securities, LLC ($14K) and XTX Topco Ltd ($12K).
- Company
- Propanc Biopharma Inc.
- CUSIP
- 74346N701
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $34K |
| Exits | 1 | $71K |
All 13F filers, Q3 2025 → Q4 2025: 63,866 shares bought and 47,082 shares sold, net +16,784 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Marex Group Ltd | 0.00% | Reduce -7.7% | 65,024 | $35K |
| Two Sigma Securities, LLC | 0.00% | New | 25,483 | $14K |
| XTX Topco Ltd | 0.00% | New | 22,126 | $12K |
| Two Sigma Investments, LP | 0.00% | New | 16,257 | $9K |
| Morgan Stanley | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is PPCB's weight in each manager's 13F, not the share of Propanc Biopharma Inc. the manager owns.